Özkan, Erdem, et al. “Baseline and Dynamic Changes in Skeletal Muscle Mass As Predictive Biomarkers in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab: Predictive Value of Sarcopenia in MRCC”. Radiology and Oncology, vol. 59, no. 4, Dec. 2025, pp. 624-3, https://www.radioloncol.com/index.php/ro/article/view/4685.